The sh-plasmid was used to interfere with METTL1 in CRC, and the results showed that sh-METTL1-1 and sh- METTL1-2 significantly reduced protein levels of METTL1 (Fig. 6E). The gene discussed is METTL1; the disease is colorectal carcinoma.